90% of patients respond to new blood cancer treatment in trial

Futurology@lemmy.mlEnglish · 2 years ago

Israeli researchers have developed a new form of CAR-T therapy effective against multiple myeloma, a plasma cell cancer.

You must log in or register to comment.

Chat